The pathogenesis and management of influenza virus infection in organ transplant recipients

Transplant Infectious Disease

Volumn 4, Issue 4, 2002, Pages 177-182

  Vilchez, R A ^a,b   Fung, J ^a   Kusne, Shimon ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Chemoprophylaxis; Influenza prevention; Influenza virus; Organ transplantation

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; TUMOR NECROSIS FACTOR; ZANAMIVIR;

GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; PATHOPHYSIOLOGY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0036969239     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2002.t01-4-02001.x     Document Type: Review

References (44)

1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations on the Advisory Committed on Immunizations Practices. MMWR Morb Mortal Wkly Rep 2000: 49 (RR-03): 1-38.
2. BRIGGS JD, TIMBURY MC, PATON AM, BELL PR. Viral infection and renal transplant rejection. Br Med J 1972: 4: 520-522.
3. KEANE WR, HEIDEMANN JH, LUBY J, GAILIUNAS P, HULL AR, KOKKO JP. Epidemic renal transplant rejection associated with influenza A/Victoria. Kidney Int 1978: 14: 793.
4. ASCHAN J, RINGDEN O, LJUNGMAN P, ANDERSSON J, LEWENSOHN-FUCHS I, FORSGREN M. Influenza B in transplant recipients. Scan J Infect Dis 1989: 21: 349-350.
5. LJUNGMAN P, ANDERSSON J, ASCHAN J, et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993: 17: 244-247.
6. MAUCH TJ, BRATTON S, MYERS T, KRANE E, GENTRY SR, KASHTAN CE. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics 1994: 94: 225-229.
7. APALSH AM, GREEN M, LEDESMA-MEDINA J, NOUR B, WALD ER. Parainfluenza nad influenza virus infection in pediatric organ transplant recipients. Clin Infet Dis 1994: 20: 394-399.
8. VILCHEZ RA, McCURRY K, DAUBER J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002: 2: 287-291.
9. VILCHEZ RA, FUNG JJ, KUSNE S. Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation 2000: 70: 543-545.
10. GARANTZIOTIS S, HOWELL DN, McADAMS HP, DAVIS D, HENSHAW NG, PALMER SM. Influenza pneumonia and association of bronchiolitis obliterans syndrome. Chest 2001: 119: 1277-1280.
11. FAUL JL, AKINDIPE OA, BERRY GJ, THEODORE J. Influenza pneumonia in a pediatric lung transplant recipient. Transpl Int 2000: 13: 79-81.
12. VILCHEZ RA, McCURRY K, DAUBER J, et al. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation 2002: 73: 1075-1078.
13. EMBREY RP, GEIST LJ. Influenza A pneumonitis following treatment of acute cardiac allograft rejection with murine monoclonal anti-CD3 antibody (OKT3). Chest 1995: 10: 1456-1459.
14. MALAVAUD S, MALAVAUD B, SANDRES K, et al. Nosocomial outbreak of influenza virus A (H3N2) infection in a solid organ transplant department. Transplantation 2001: 72: 535-537.
15. WENZEL RP, HENDLEY JO, SANDE MA, GWALTNEY JM Jr. Revised (1972-73) bivalent influenza vaccine. Serum and nasal antibody responses to parental vaccination. JAMA 1973: 226: 435-438.
16. KILBOURNE ED, BUTTLER WT, ROSSEN RC. Specific immunity in influenza: summary of influenza workshop III. J Infect Dis 1973: 127: 220.
17. BETTS RF, O'BRIEN DM, MENEGUS M, et al. A comparison of the protective benefits of influenza vaccine in reducing hospitalization of patients infected with influenza A and B [Abstract]. Clin Infect Dis 1993: 17: 573.
18. BLUMBERG EA, ALBANO C, PRUETT T, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996: 22: 295-302.
19. FRAUD S, WAGNER D, PETHIG K, DRESCHER J, GIRGSDIES OE, HAVERICH A. Influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1999: 18: 220-225.
20. KUMAR SS, VENTURA AK, VANDER WERF B. Influenza vaccination in renal transplant recipients. JAMA 1978: 239: 840-842.
21. VERSIUS DJ, BEYER WEP, MASUREL N, WENTING GJ, WEIMAR W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine but not azathioprine. Transplantation 1986: 42: 376-379.
22. GLEZEN WP. Reactive airway disorders in children: role of respiratory virus infections. Clin Chest Med 1984: 5: 635-643.
23. ATMAR RL, BAXTER BD, DOMINGUEZ EA, TABER LH. Comparison of reverse transcription-PCR with tissue culture and other rapid diagnostic assays for detection of type A influenza virus. J Clin Microbiol 1996: 34: 2604-2606.
24. MANN JJ, WALDERMAN RH, TOGO Y, HEINER G, DAWKINS AT, KASEL JA. Antibody response in respiratory secretions of volunteers given live and dead influenza virus. J Immunol 1968: 100: 726-735.
25. PONEGAR KB, SMALL PA JR. Immunoglobulin A: Mediation of murine nasal anti-influenza virus immunity. J Virol 1991: 65: 2146-2148.
26. COUCH RB, DOUGLAS RG JR, et al. Role of secretory antibody in influenza. In: DAYTON DH JR, SMALL PA JR, CHANOCK RM, et al. eds. The Secretory Immunologic System. Washington DC. US GPO 1969: 93.
27. SINGHAL S, MUIR DA, RATCLIFFE DA, et al. Respiratory viruses in liver transplant recipients. Transplantation 1999: 68: 981-984.
28. SKONER DP, GENTILE DA, PATEL A, DOYLE WJ. Evidence of cytokine mediation of disease expression in adults experimentally infected with influenza A. J Infect Dis 1999: 180: 10-14.
29. HOLT ND, GOULD FK, TAYLOR CE, et al. Incidence and significance of noncytomegalovirus viral respiratory infection after adult lung transplantation. J Heart Lung Transplant 1997: 16: 416-419.
30. VILCHEZ RA, McCURRY K, DAUBER J, et al. The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis 2001: 33: 2004-2008.
31. STIVER HG, GRAVES P, EIKHOFF TC, et al. Efficacy of 'Hong Kong' vaccine in preventing 'England' variant influenza A in 1972. N Engl J Med 1973: 289: 1267-1271.
32. RUBEN FL, JOHNSTON F, STREIFF EJ. Influenza in partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA 1974: 230: 863-866.
33. NICHOL KL, MENDELMAN PM, MALLON KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy working adults: a randomized controlled trial. JAMA 1999: 282: 137-144.
34. BELSHE RB, MENDELMAN PM, TREANOR J, et al. Efficacy of live attenuated cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998: 338: 1405-1412.
35. NOYOLA DE, CLARK B, O'DONNELL FT, ATMAR RL, GREER J, DEMMLER GJ.; Comparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B in nasal wash specimens. J Clin Microbiol 2000: 38: 1161-1165.
36. DOLIN R, REICHMAN RC, MADORE HP, MAYNARD R, LINTON N, WEBBER-JONES J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Eng J Med 1982: 307: 580-584.
37. BETTS RF, TREATNOR JJ, GRAMAN PS, et al. Antiviral agents to prevent or treat influenza in the elderly. J Respir Dis 1987: 8: 56.
38. BRADY MT, SEARS SD, PACINI DL, et al. Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic. Antimicrob Agent Chemother 1990: 34: 1633-1636.
39. KIM CU, LEW W, WILLIAMS MA, et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocylic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc 1997: 119: 681-690.
40. MUNOS FM, GALASSO GJ, GWALTNEY JM, et al. Current research on influenza and other respiratory viruses: II International Symposium. Antiviral Res 2000: 46: 91-124.
41. HAYDEN FG, GUBAREVA LV, MONTO AS, et al. Inhaled zanamivir for the prevention of influenza and families. Zanamivir Family Study Group. N Engl J Med 2000: 343: 1282-1289.
42. HAY AJ, WOLSTENHOLME AJ, SKEHEL JJ, SMITH MH. The molecular basis of the specific antiinfluenza action of amantidine. EMBO J 1985: 4: 3021-3024.
43. ENGLUND JA, CHAPLIM RE, WYDE PR, et al. Common emergence of amantidine and rimantadine resistant influenza A viruses in symptomatic immunocom-promised patients. J Infect Dis 1998: 26: 1418-1424.
44. GUBAREVA LV, MATROSOVICH MN, BRENNER MK, BETHELL RC, WEBSTER RG. Evidence of zanamivir resistance in an immunocompromised child infected with influenza B. J Infect Dis 1998: 178: 1257-1262.